This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Verseau Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Igor Feldman: Innovator in Myeloid Cell Modulation
Introduction
Igor Feldman is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of myeloid cell inflammatory phenotypes. His work is crucial for advancing therapeutic strategies in various inflammatory diseases.
Latest Patents
Igor Feldman holds a patent titled "Anti-PSGL-1 Compositions and Methods for Modulating Myeloid Cell Inflammatory Phenotypes and Uses Thereof." This patent represents his innovative approach to addressing inflammation at the cellular level. He has 1 patent to his name, showcasing his commitment to advancing scientific knowledge and therapeutic applications.
Career Highlights
Igor is currently employed at Verseau Therapeutics, Inc., where he continues to develop groundbreaking therapies. His role at the company allows him to collaborate with other experts in the field and contribute to the advancement of medical science.
Collaborations
Igor has worked alongside talented colleagues, including Tatiana I Novobrantseva and Joseph A Wahle. These collaborations enhance the research environment and foster innovation in their projects.
Conclusion
Igor Feldman's work in the modulation of myeloid cell inflammatory phenotypes exemplifies the impact of innovative research in medicine. His contributions are paving the way for new therapeutic approaches to combat inflammation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile